Prevention Genetics LogoExact Sciences is now Abbott
Test Code 10265
New York approved

Congenital Hyperinsulinism Panel

9 genes

2 - 3 weeks (6 - 12 days STAT)

Who is this test for?
  • Individuals with relevant features who have a clinical or suspected diagnosis of congenital hyperinsulinism (CHI)
  • Individuals with disease onset in the neonatal period or early infancy
  • Individuals with diazoxide-unresponsive hypoglycemia requiring aggressive medical management
  • Reproductive partners of individuals with a known pathogenic variant in CHI-associated genes
Method
NGS with CNV (Exome or Genome Platform)
Specimen(s)

Exome Platform: Blood, DNA, Buccal, Saliva, Tissue

Genome Platform: Blood, DNA

Order Options

OTHER OPTIONS
for standard institutional pricing.

Explore related tests

Questions? We can help.

Getting support has never been easier. Let us connect you with our specialists that will assist you with anything from understanding products to navigating insurance questions.